TERRA seed

What TERRA seed does

TERRA seed Sp. z o.o. is a Polish seed capital fund headquartered in Kraków that finances early-stage technology projects in the Proof of Principle and Proof of Concept phases, with a primary focus on life sciences and deep tech. Originally established as ABAN Fund in 2017, the firm rebranded to TERRA seed in 2022 and is registered with Poland's Financial Supervision Commission (KNF) as Alternative Investment Company (ASI) Manager No. 19. The fund secured 25,104,000 PLN in non-dilutive grant financing from the National Centre for Research and Development (NCBiR) under the BRIdge Alfa program in 2017 after achieving the highest score among 98 applicants, and subsequently deployed capital into 25 innovative R&D projects through project POIR.01.03.01-00-0005/17 (2018-2023).

The fund's portfolio comprises 15 disclosed companies spanning medtech (Acti Stent, Clandev, Myokyon, EFM R&D, Warmie), telemedicine (TelDoc), veterinary diagnostics (PETS Diag), computer vision (CitiesAI, RTG Vision), low-code software (Codejet), travel tech (Getaway International), renewable energy (Enalpha PWR Ability), satellite telecommunications (Thorium Space), industrial AI (Verii), and smart housing (INcabin). TERRA seed sources deals through direct engagement with Polish scientific institutions and via its Lifescience Cluster membership (held since 2019), while leveraging an investment committee with backgrounds spanning pharma commercialization, medical university technology transfer, and corporate strategy at Procter & Gamble, Mondelez, and Polpharma.

TERRA seed operates a closed-end, externally managed ASI structure accepting professional investors meeting Polish AFI regulatory thresholds (minimum 60,000 EUR contribution). The fund generates returns through equity stakes in portfolio companies, with monetization dependent on future exits via acquisitions, IPOs, or secondary sales; specific fund terms, management fees, and carried interest structures are not publicly disclosed. The operating entity holds share capital of just 15,000 PLN, indicating a lean GP cost structure supported by the public grant co-funding model.

Name

TERRA seed

Legal name

TERRA seed Sp. z o.o.

Website

https://terraseed.pl

Company type

Private

Founded year

2017

Operating status

Operating

Ownership category

akta.pro rank

Product category

Seed Capital / Venture Capital Fund

NAICS

Portfolio Management and Investment Advice (523940), Other Investment Pools and Funds (5259)

akta.pro primary industry

Early-Stage Venture Capital (Pre-Seed/Seed) (FSANAAAA)

akta.pro secondary industry

Emerging Managers / Seeding Platforms (FSAHAKAI)

Keywords

• Seed capital fund
• Venture capital
• Early-stage investing
• Life science investment
• Technology commercialization

Headquarters

HQ city

Cracow

HQ country

Poland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Investment Returns: As a seed capital fund, TERRA seed generates returns through equity investments in early-stage companies. The fund takes ownership stakes in portfolio companies in exchange for financing, expecting returns through exits via acquisitions, IPOs, or secondary sales.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

TERRA seed is a Polish seed capital fund that invests equity into early-stage technology and life science projects in the Proof of Principle and Proof of Concept phases. The fund finances 25 innovative R&D projects originating from Polish research institutions, providing seed capital combined with commercialization expertise, investment committee oversight, and access to academic and industry networks. It is registered as Alternative Investment Company Manager No. 19 under the supervision of Poland's Financial Supervision Commission (KNF).

Product overview

TERRA seed is a seed capital fund (registered under KNF as Alternative Investment Company Manager No. 19) that finances innovative technology projects in the Proof of Principle and Proof of Concept phases. The fund does not operate a single unified product but maintains a diversified portfolio of 15 portfolio companies spanning medtech, telemedicine, veterinary diagnostics, low-code software, computer vision, travel tech, renewable energy, satellite telecommunications, and smart housing. Each portfolio company operates as an independent entity with its own product. Key portfolio products include Warmie (remote wound monitoring), TelDoc (telemedicine automation), Myokyon (mioelectric prosthetics interface), EFM R&D Mudisocard (heart failure diagnostics), Codejet (Figma-to-code low-code platform), CitiesAI (retail footfall analytics), Getaway International (AI-powered travel planning), Enalpha PWR Ability (prosumer energy management), and Thorium Space (satellite communication systems).

Differentiator

Problem solved

Functional benefit

Products and services

• TERRA seed Capital Fund (Alternatywna Spółka Inwestycyjna) Closed-end seed capital fund providing equity financing to early-stage technology and life science projects in the Proof of Principle and Proof of Concept phases, available to professional investors under Polish AFI regulations with a minimum 60,000 EUR equivalent commitment.
• R+D Project Co-financing Program (POIR.01.03.01-00-0005/17) Structured R+D co-financing program that combined the most effective practices for supporting technological start-up development with market-success know-how to support commercialization of R+D projects from Polish scientific institutions.

Quantifiable outcome

• 25 innovative B+R projects funded through BRIdge Alfa program
• +1 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability14 records

Partnerships

One partnership is on record.

• Lifescience ClustercoreStrategic or Co-development Partner · 1 January 2019TERRA seed has been a member of the Lifescience Cluster since 2019. Fund representatives actively engage in cluster activities, providing deal sourcing, mentorship, and ecosystem development within the Polish life science community.

Scale indicators5 records

Recent moves7 records

Expansion highlights4 records

Direct peers

• Market One Capital: Polish early-stage B2B-focused VC fund writing seed and Series A tickets into CEE founders. Operates with a similar institutional Polish fund structure and frequently co-invests in the same ecosystem as TERRA seed.
• Hiventures: Hungarian state-backed early-stage VC manager operating a portfolio of seed and growth vehicles with EU/regional public co-investment (similar to BRIdge Alfa model). Provides a directly comparable Central European regulated VC-manager operating model.
• Credo Ventures: Czech early-stage VC fund investing in seed and Series A rounds across Central Europe, with comparable sector mix (SaaS, deep tech, life science adjacencies) and ticket sizes overlapping with TERRA seed's PoP/PoC investments.
• Day One Capital: Hungarian early-stage VC fund with CEE-wide deal sourcing, writing seed and Series A tickets into tech startups. Comparable in stage, ticket size, and Central European early-stage technology focus to TERRA seed.
• Balnord: Polish deep tech VC backed by Polish Development Fund (PFR) and EIF investing in seed/early-stage deep tech, similar in regulated public-co-investment structure and sector focus to TERRA seed's deep tech and life science investments.
• Shape.vc: Polish early-stage VC investing in CEE-based tech founders at seed stage, with comparable ticket size and focus on B2B technology companies emerging from Central Europe.
• SpeedUp Group: Polish seed and early-stage VC fund manager running multiple vehicles (including corporate-backed and accelerator-style funds) with comparable ticket sizes and Polish pre-seed deal-flow overlap.
• OTB Ventures: Poland-domiciled deep tech VC fund investing across space, AI, enterprise software, and fintech with comparable ticket sizes. Strongly comparable to TERRA seed's deep tech and space portfolio exposure (e.g., Thorium Space).
• inovo.vc: Polish early-stage VC fund investing in technology startups at pre-seed and seed stages, with a comparable Polish-domestic focus and ticket sizes that overlap with TERRA seed's pre-seed/PoC strategy.
• Arkley Brinc VC: Polish seed VC formed by the merger of Arkley and Brinc Poland, deploying seed tickets into Polish and Central European technology startups. Operates at the same pre-seed/seed stage as TERRA seed with a similar Polish-anchored LP base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks4 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/ABAN-Fund-2128354204100469
• LinkedInlinkedin.com/company/aban-fund

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TERRA seed